Vonjo savings card: as little as $25 a fill with commercial insurance

How to pay the least

Ask for the cash price

Vonjo

We didn’t find one.

Ask your pharmacy for Vonjo’s cash price, and one or two other pharmacies too.
Vonjo’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameVonjo

Authorized genericpacritinib

Regular genericpacritinib

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Vonjo?

The original

–

Brand nameThe maker’s card

VONJO Copay Assistance Program (VONJO Connect)

Savings card from Sobi

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $25 a fill

The card takes up to $25,000 a year off your co-pay.

Or call 1-888-284-3678. See the offer on vonjo.com

In the maker’s words

“VONJO Copay Assistance Program is for eligible patients who have commercial prescription insurance. You may pay as little as $25 per prescription fill, up to a maximum benefit of $25,000 for a 12-month period.”

From the maker’s offer on vonjo.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Vonjo itself, from the same company, sold without the brand name, and usually for less. For now Vonjo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Myelofibrosis with a low platelet count

What the FDA label says

VONJO is a kinase inhibitor indicated for the treatment of adults with intermediate or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis with a platelet count below 50 × 109/L.

This indication is approved under accelerated approval based on spleen volume reduction. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

Source: the FDA label for Vonjo (Sobi, Inc.), July 30, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/vonjo/